Join Growin Stock Community!

Longeveron inc.LGVN.US Overview

US StockHealthcare
(No presentation for LGVN)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

LGVN AI Insights

LGVN Overall Performance

LGVN AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

LGVN Recent Performance

-0.44%

Longeveron inc.

0.05%

Avg of Sector

-0.31%

S&P500

LGVN PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

LGVN Key Information

LGVN Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

LGVN Profile

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Price of LGVN

LGVN FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

LGVN Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.00
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
8.04
PB Ratio
1.22
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
74.88%
Net Margin
-1485.11%
Revenue Growth (YoY)
-22.41%
Profit Growth (YoY)
-20.47%
3-Year Revenue Growth
-19.74%
3-Year Profit Growth
10.76%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.00
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
8.04
PB Ratio
1.22
Price-to-FCF
-
Gross Margin
74.88%
Net Margin
-1485.11%
Revenue Growth (YoY)
-22.41%
Profit Growth (YoY)
-20.47%
3-Year Revenue Growth
-19.74%
3-Year Profit Growth
10.76%
  • When is LGVN's latest earnings report released?

    The most recent financial report for Longeveron inc. (LGVN) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating LGVN's short-term business performance and financial health. For the latest updates on LGVN's earnings releases, visit this page regularly.

  • What is the operating profit of LGVN?

    According to the latest financial report, Longeveron inc. (LGVN) reported an Operating Profit of -7.31M with an Operating Margin of -5,335.77% this period, representing a decline of 57.24% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is LGVN's revenue growth?

    In the latest financial report, Longeveron inc. (LGVN) announced revenue of 137K, with a Year-Over-Year growth rate of -82.28%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does LGVN have?

    As of the end of the reporting period, Longeveron inc. (LGVN) had total debt of 983K, with a debt ratio of 0.06. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does LGVN have?

    At the end of the period, Longeveron inc. (LGVN) held Total Cash and Cash Equivalents of 9.24M, accounting for 0.59 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does LGVN go with three margins increasing?

    In the latest report, Longeveron inc. (LGVN) did not achieve the “three margins increasing” benchmark, with a gross margin of 91.2%%, operating margin of -5,335.77%%, and net margin of -5,270.8%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess LGVN's profit trajectory and future growth potential.

  • Is LGVN's EPS continuing to grow?

    According to the past four quarterly reports, Longeveron inc. (LGVN)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.39. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of LGVN?

    Longeveron inc. (LGVN)'s Free Cash Flow (FCF) for the period is -5.11M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 56.19% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of LGVN?

    The latest valuation data shows Longeveron inc. (LGVN) has a Price-To-Earnings (PE) ratio of -0.8 and a Price/Earnings-To-Growth (PEG) ratio of -0.03. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.